List of works - Cyrus P Zabetian

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

scientific article

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

scientific article (publication date: July 2008)

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

scientific article

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

scientific article

Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database

scientific article

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

scientific article

The genetics of Parkinson disease

scientific article

APOE ε4 increases risk for dementia in pure synucleinopathies

scientific article published on February 2013

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

scientific article

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

scientific article published in August 2006

A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus

scientific article

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

scientific article

Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee

scientific article published in August 2011

Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area.

scientific article published in June 2005

Phosphorylated α-synuclein in Parkinson's disease

scientific article

Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome

scientific article published on 14 February 2017

Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders

scientific article

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

scientific article

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

scientific article

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

scientific article

Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.

scientific article published on 24 February 2011

A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations

article

Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology

scientific article published on 16 April 2004

Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk

scientific article published in January 2008

A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology

scientific article published on 17 April 2007

Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease

scientific article

Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease.

scientific article published on 12 March 2008

GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology

scientific article

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease

scientific article

GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease

scientific article

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

scientific article

Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS).

scientific article

Association of Parkinson disease with structural and regulatory variants in the HLA region

scientific article published on 31 October 2013

Human PON1, a biomarker of risk of disease and exposure

scientific article

LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.

scientific article

Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease

scientific article published on 29 August 2016

Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study

scientific article

Exploring gene-environment interactions in Parkinson’s disease

article

A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2

scientific article

Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.

scientific article

The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity

scientific article

Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics

scientific article

Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations

scientific article published in September 2006

Genetic association between α-synuclein and idiopathic parkinson's disease

article

DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease

scientific article

Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.

scientific article

Heterozygousparkinpoint mutations are as common in control subjects as in Parkinson's patients

article

A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function

scientific article

Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy

scientific article

LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease

scientific article

List of works by Cyrus P Zabetian

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

The genetics of Parkinson disease

APOE ε4 increases risk for dementia in pure synucleinopathies

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee

Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area.

Phosphorylated α-synuclein in Parkinson's disease

Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome

Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.

A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations

Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology

Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk

A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology

Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease

Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease.

GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease

GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease

Plasma apolipoprotein A1 as a biomarker for Parkinson disease

Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS).

Association of Parkinson disease with structural and regulatory variants in the HLA region

Human PON1, a biomarker of risk of disease and exposure

LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.

Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease

Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study

Exploring gene-environment interactions in Parkinson’s disease

A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2

Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.

The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity

Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics

Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations

Genetic association between α-synuclein and idiopathic parkinson's disease

DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease

Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.

Heterozygousparkinpoint mutations are as common in control subjects as in Parkinson's patients

A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function

Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy

LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease